What are expectations that can come from the Accelerating Medicines Partnership?

Virginia Ladd - AMP

Submitted by Julie on Mon, 03/17/2014 - 12:45

Autoimmune diseases affect 50 million Americans and are a leading cause of death and disability — yet we have no cure. Historically, the first goal of treatment is to reduce inflammation focusing on making quality of life as good as possible. However, more needs to be done on greater research options for all autoimmune disease-related patients.

Share
Email
Print

var switchTo5x = false;var __st_loadLate = true;stLight.options({"publisher":"dr-e0d16a36-b72f-d979-d8a1-314a351971a6"});

$('#shareSocial').click(function(e) { e.preventDefault(); openSocial(); });

function openSocial() {
$('#shareSocial').toggleClass('active');
$('#social').slideToggle();
}

Sign-up for Updates

Subscribe to RSS

Lon Cardon - AMP

Submitted by Julie on Mon, 03/17/2014 - 12:46

Alzheimer’s disease in the United States is the sixth leading cause of death with more than five million Americans currently struggling with it on a daily basis. Alzheimer’s also represents an area of treatment which has largely failed to materialize.

Share
Email
Print

var switchTo5x = false;var __st_loadLate = true;stLight.options({"publisher":"dr-e0d16a36-b72f-d979-d8a1-3...

Source: PHRMA - March 17, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news